The Consumer Staples group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Has MEDIFAST INC (MED) been one of those stocks this year? Let's take a closer look at the stock's year-to-date performance to find out.
MEDIFAST INC is a member of the Consumer Staples sector. This group includes 169 individual stocks and currently holds a Zacks Sector Rank of #10. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.
The Zacks Rank is a proven model that highlights a variety of stocks with the right characteristics to outperform the market over the next one to three months. The system emphasizes earnings estimate revisions and favors companies with improving earnings outlooks. MED is currently sporting a Zacks Rank of #1 (Strong Buy).
Within the past quarter, the Zacks Consensus Estimate for MED's full-year earnings has moved 11.45% higher. This shows that analyst sentiment has improved and the company's earnings outlook is stronger.
According to our latest data, MED has moved about 5.41% on a year-to-date basis. Meanwhile, the Consumer Staples sector has returned an average of 10.81% on a year-to-date basis. This means that MEDIFAST INC is performing better than its sector in terms of year-to-date returns.
Breaking things down more, MED is a member of the Food - Miscellaneous industry, which includes 40 individual companies and currently sits at #100 in the Zacks Industry Rank. This group has gained an average of 4.48% so far this year, so MED is performing better in this area.
Investors in the Consumer Staples sector will want to keep a close eye on MED as it attempts to continue its solid performance.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
MEDIFAST INC (MED) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research